Hong Kong Clears Europharm Products Of Fungus, Plant Still Shut
This article was originally published in PharmAsia News
Hong Kong health authorities have now cleared all 359 of Europharm's drug products of containing a fungal growth found in gout products. Although the Hong Kong Department of Health said it plans to continue testing, it said examinations of 39 raw material samples from the drug maker uncovered none of the Rhizopus microsporus fungus implicated in at least six Hong Kong fatalities. But the department also said Europharm could not resume manufacturing operations until it has improved its production lines to the satisfaction of authorities. (Click here for more
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.